XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.2
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted shares
Restricted stock units
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Restricted shares
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted shares
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Non-controlling interests in consolidated entities
Beginning balance (in shares) at Dec. 31, 2023             223,938,000                
Balances at beginning of period at Dec. 31, 2023 $ 9,697.1     $ 9,505.1     $ 44.8     $ 431.7     $ 9,076.1 $ (47.5) $ 192.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,068.0     1,057.2                 1,057.2   10.8
Other comprehensive income (loss), net of tax (1.7)     (1.7)                   (1.7)  
Dividends declared (568.5)     (568.5)                 (568.5)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             295,000                
Shares issued upon option exercises 18.4     18.4     $ 0.1     18.3          
Restricted shares issued, net of shares withheld for taxes (in shares)               7,000              
Restricted shares issued, net of shares withheld for taxes   $ (0.3)     $ (0.3)           $ (0.3)        
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (in shares)                 56,000            
Net shares issued upon vesting of restricted stock units     $ (1.8)     $ (1.8)           $ (1.8)      
Stock-based compensation expense 112.7     112.7           112.7          
Restricted stock units issued as dividend equivalents 0.0                 0.2     (0.2)    
Common shares repurchased (in shares)             (1,684,000)                
Common shares repurchased (192.4)     (192.4)     $ (0.4)     (192.0)          
Net contributions to non-controlling interests in consolidated entities 2.5                           2.5
Ending balance (in shares) at Jun. 30, 2024             222,612,000                
Balances at end of period at Jun. 30, 2024 10,134.0     9,928.7     $ 44.5     368.8     9,564.6 (49.2) 205.3
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2023 594.1                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 21.5                            
Other comprehensive income (loss), net of tax (1.2)                            
Net subscriptions into T. Rowe Price investment products 170.8                            
Net deconsolidations of T. Rowe Price investment products (96.2)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2024 689.0                            
Beginning balance (in shares) at Mar. 31, 2024             223,494,000                
Balances at beginning of period at Mar. 31, 2024 9,989.5     9,784.1     $ 44.7     424.2     9,364.8 (49.6) 205.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 481.0     483.4                 483.4   (2.4)
Other comprehensive income (loss), net of tax 0.4     0.4                   0.4  
Dividends declared (283.5)     (283.5)                 (283.5)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             49,000                
Shares issued upon option exercises 3.0     3.0     $ 0.1     2.9          
Restricted shares issued, net of shares withheld for taxes (in shares)               7,000              
Restricted shares issued, net of shares withheld for taxes   (0.3)     (0.3)           (0.3)        
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (in shares)             29,000                
Net shares issued upon vesting of restricted stock units (0.4)     (0.4)           (0.4)          
Stock-based compensation expense 54.3     54.3           54.3          
Restricted stock units issued as dividend equivalents 0.0                 0.1     (0.1)    
Common shares repurchased (in shares)             (967,000)                
Common shares repurchased (112.3)     (112.3)     $ (0.3)     (112.0)          
Net contributions to non-controlling interests in consolidated entities 2.3                           2.3
Ending balance (in shares) at Jun. 30, 2024             222,612,000                
Balances at end of period at Jun. 30, 2024 10,134.0     9,928.7     $ 44.5     368.8     9,564.6 (49.2) 205.3
Beginning balances attributable to redeemable non-controlling interests at Mar. 31, 2024 676.7                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 1.9                            
Other comprehensive income (loss), net of tax 0.4                            
Net subscriptions into T. Rowe Price investment products 78.1                            
Net deconsolidations of T. Rowe Price investment products (68.1)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2024 689.0                            
Beginning balance (in shares) at Dec. 31, 2024             222,966,000                
Balances at beginning of period at Dec. 31, 2024 10,506.1     10,345.4     $ 44.6     311.9     10,040.6 (51.7) 160.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 993.8     995.7                 995.7   (1.9)
Other comprehensive income (loss), net of tax 7.1     7.1                   7.1  
Dividends declared $ (574.9)     (574.9)                 (574.9)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares) 367,630           264,000                
Shares issued upon option exercises $ 17.2     17.2     $ 0.1     17.1          
Restricted shares issued, net of shares withheld for taxes (in shares)               8,000              
Restricted shares issued, net of shares withheld for taxes   (0.2)     (0.2)           (0.2)        
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (in shares)                 15,000            
Net shares issued upon vesting of restricted stock units     $ (0.6)     $ (0.6)           $ (0.6)      
Stock-based compensation expense 96.9     96.9           96.9          
Restricted stock units issued as dividend equivalents 0.0                 0.1     (0.1)    
Common shares repurchased (in shares)             (3,351,000)                
Common shares repurchased (326.1)     (326.1)     $ (0.7)     (325.4)          
Net contributions to non-controlling interests in consolidated entities (5.5)                           (5.5)
Ending balance (in shares) at Jun. 30, 2025             219,902,000                
Balances at end of period at Jun. 30, 2025 10,713.8     10,560.5     $ 44.0     99.8     10,461.3 (44.6) 153.3
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2024 944.0                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 65.5                            
Other comprehensive income (loss), net of tax 11.0                            
Net subscriptions into T. Rowe Price investment products 259.7                            
Net deconsolidations of T. Rowe Price investment products (181.1)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2025 1,099.1                            
Beginning balance (in shares) at Mar. 31, 2025             221,061,000                
Balances at beginning of period at Mar. 31, 2025 10,555.1     10,394.7     $ 44.2     160.2     10,242.2 (51.9) 160.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 503.7     505.2                 505.2   (1.5)
Other comprehensive income (loss), net of tax 7.3     7.3                   7.3  
Dividends declared (286.1)     (286.1)                 (286.1)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             33,000                
Shares issued upon option exercises 2.0     2.0     $ 0.1     1.9          
Restricted shares issued, net of shares withheld for taxes (in shares)               8,000              
Restricted shares issued, net of shares withheld for taxes   $ (0.2)     $ (0.2)           $ (0.2)        
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (in shares)             10,000                
Net shares issued upon vesting of restricted stock units (0.4)     (0.4)           (0.4)          
Stock-based compensation expense 46.6     46.6           46.6          
Common shares repurchased (in shares)             (1,210,000)                
Common shares repurchased (108.6)     (108.6)     $ (0.3)     (108.3)          
Net contributions to non-controlling interests in consolidated entities (5.6)                           (5.6)
Ending balance (in shares) at Jun. 30, 2025             219,902,000                
Balances at end of period at Jun. 30, 2025 10,713.8     $ 10,560.5     $ 44.0     $ 99.8     $ 10,461.3 $ (44.6) $ 153.3
Beginning balances attributable to redeemable non-controlling interests at Mar. 31, 2025 977.2                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 50.9                            
Other comprehensive income (loss), net of tax 7.9                            
Net subscriptions into T. Rowe Price investment products 169.1                            
Net deconsolidations of T. Rowe Price investment products (106.0)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2025 $ 1,099.1                            
[1] Accumulated other comprehensive income